dual Raf/HDAC inhibitors (China Pharmaceutical University/Northwest A&F University)

N/A

Report date: 2025/03/18 18:13:21
NME

Base Information

Drug Namedual Raf/HDAC inhibitors (China Pharmaceutical University/Northwest A&F University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 1 inhibitorsSerine/threonine-protein kinase B-raf inhibitors
TargetsHistone deacetylase 1Serine/threonine-protein kinase B-raf
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChina Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesNorthwest A&F UniversityChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A